Replies to post #130869 on NanoViricides Inc (NNVC)

[arvitar]

Given that Diwan has NEVER scaled up a process of any kind in his life, and has absolutely no experience of any kind in the pharma industry..

there are literally thousands of process chemists out there who know infinitely more about it than Diwan.

Given Diwan's complete and total lack of success after 12 years and $80 MILLION spent, investors should be quite worried if the above statement is false. Obviously experience in synthesizing small batches at the bench isn't transferable to successful scale-up. That's why there are chemists in the pharma industry who specialize in doing exactly that.

If Diwan is as good as it gets, and it's impossible for experienced pharma process chemists who have spent their entire careers solving tricky scale-up problems for novel compounds to do better than Diwan, that's hardly a ringing endorsement for this POS.

[medcac]

When I started out here I said that a year ago when I first got in to NNVC I did some very basic research and my impression from what I read was that a lot of people were working with similar nano particles but that the problem facing everyone was keeping the formulates intact in solution. I bought on a bet that NNVC might be the people to solve that problem. If not it goes a long way to explaining the delays. Maybe when they make a batch it works wonders but when they come to the lab the next day it is mush.

The relationship with Theracour was explained to me in the beginning (by a cheerleader) as a shield to prevent big pharma from attacking NNVC with a cheap offering below the true value of the ultimate value of the discovery, if indeed the process could be continued for all viruses. Likewise the special voting shares that make a takeover impossible without the Principal's consent. All this is also possible as part of a scenario to deceive.

I still don't get the $5.20 Target Price.